Jump to content

Jjwb

Members
  • Posts

    3
  • Joined

  • Last visited

Profile Information

  • City
    Hockessin
  • US State (if applicable)
    DELAWARE
  • Province or district (if non-US)
    DE
  • Country
    United States
  • Status
    Not a patient
  • Interests
    Small cell lung cancer

Recent Profile Visitors

The recent visitors block is disabled and is not being shown to other users.

  1. Hi Tom, Many thanks for this very helpful information. My wife has a primary lung tumor that has shrunk with chemo/immuno. She also has lymph node involvement and small lesions on her spine that don’t appear to have been changed by chemo/immuno. The radiation oncologist has indicated that these will all be targeted during ten sessions of radiation. We are hopeful that radiation will continue her positive progress. Thanks again and best wishes, John
  2. Hi, I hope your mom is doing well. My wife is on a clinical trial that involves Zepzelca after 4 cycles of carboplatin/etoposide/Tecentriq, but was recently randomized to the non-Zepzelca part of the maintenance phase. As a result, she will probably exit the trial, and after a consultation with a radiation oncologist, start radiation together with Tecentriq. We would really like to hear about your decision and how it is working. Best Wishes.
  3. My wife was diagnosed with E-SCLC in December 2022 - about 4 cm lung tumor and some spine lesions. She started a clinical trial of carboplatin/etoposide/ atezolizumab (Tecentriq) in January, with the potential to get atezolizumab/lurbinectedin in the maintenance phase of the trial. The first part of the trial went quite well, with the primary tumor shrinking about 50% after the first two sessions, but then did not shrink further. She was randomized to atezolizumab only (no lurbinectedin) for the maintenance phase, so we are pretty sure we are going to exit the trial and start radiation together with atezolizumab (after consulting with a radiation oncologist). We would greatly appreciate any advice or experience on this course of action, and thank you for all the great content on this site!
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.